Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1982-03-01
1989-01-03
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544218, 544295, 544296, 544298, 544331, 544333, 544357, 544364, 544366, 544367, 544369, 548128, 548130, 548131, 548133, 548184, 548190, 548191, 548194, 548225, 548228, 548235, 548252, 548255, 548263, 548265, 548266, 548267, 548269, 548336, 548348, 548374, A61K 31495, C07D40304
Patent
active
047957557
ABSTRACT:
This invention relates to heterocyclic derivatives which are histamine H-2 antagonists and which inhibit gastric acid secretion. According to the invention there is provided a guanidine derivative of the formula I: ##STR1## in which R.sup.1 and R.sup.2, same or different, are hydrogen or 1-10C alkyl, 3-8C cycloalkyl, 4-14C cycloalkylalkyl, each alkyl, cycloalkyl or cycloalkylalkyl optionally carrying one or more F, Cl or Br atoms, provided that one of R.sup.1 and R.sup.2 is halogen-substituted, or R.sup.2 is hydrogen and R.sup.1 is R.sup.5 -E-W- in which W is 2-6 alkylene optionally substituted by 1 or 2 1-4C alkyls, E is O,S,SO,SO.sub.2 or NR.sup.6 in which R.sup.6 is H or 1-6C alkyl, R.sup.5 is H or 1-6C alkyl optionally substituted by 1 or 2 1-4C alkyls, or R.sup.5 and R.sup.6 are joined to form a pyrrolidine, piperidine, morpholine, piperazine or N-methylpiperazine ring; ring X is a heterocyclic ring as defined in the specification; A is phenylene or 5-7C cycloalkylene, or a 1-8C alkylene into which is optionally inserted one or two groups; and R.sup.3 and R.sup.4 are a variety of radicals described in the specification: and the pharmaceutically-acceptable acid-addition salts thereof. Manufacturing processes and pharmaceutical compositions are also described.
REFERENCES:
patent: 4165377 (1979-08-01), Jones et al.
patent: 4165378 (1979-08-01), Gilman et al.
patent: 4242350 (1980-12-01), Yellin et al.
patent: 4242351 (1980-12-01), Yellin et al.
patent: 4252819 (1981-02-01), Hirata
patent: 4315009 (1982-02-01), Jones et al.
patent: 4342765 (1982-08-01), Jones et al.
patent: 4362728 (1982-12-01), Yellin et al.
"Derwent Abstracts", 48522, D/27, B03, Yama 10/12/79, p. 87.
"Derwent Abstracts", 82525 D/45, B03, Yama 2/29/80, p. 33.
"Derwent Abstracts", 22898 E/12, B03(B02), Yama 7/22/80, p. 76.
"Derwent Abstracts", 22901 E/12, B03, Yama 7/22/80, p. 78.
"Derwent Abstracts", 22902 E/12, B03, Yama 7/23/80, p. 79.
"Derwent Abstracts", 74415 C/42, B03, Yama 2/28/79.
"Derwent Abstracts", 74408 C/42, B03, Yama, 3/2/79.
Jones Derrick F.
Oldham Keith
Hollrah Glennon H.
Imperial Chemical Industries plc
Turnipseed James H.
LandOfFree
Heterocyclic derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2168681